A Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of RPH-035 and Ocrevus® in Patients With Relapsing-remitting or Secondary Progressive Multiple Sclerosis With Exacerbations
Clinical trial NCT07597668 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07597668
- Sponsor
- R-Pharm
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-16
- Primary completion
- 2026-06-02
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.